Nektar Therapeutics (NKTR)
NASDAQ:NKTR
Nektar Therapeutics (NKTR) Ownership Overview
3.71% Insiders
7.41% Mutual Funds
30.50% Other Institutional Investors
5.03% ETFs
53.35% Public Companies and Individual Investors
The ownership structure of Nektar Therapeutics (NKTR) stock is a mix of institutional, retail, and individual investors. Approximately 42.94% of the company’s stock is owned by Institutional Investors, 3.71% is owned by Insiders, and 53.35% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Feb 20, 2026 | xxxxxxxxxxxxx | $13140 | |
Feb 20, 2026 | xxxxxxxxxxxxx | $30879 | |
Nov 25, 2025 | xxxxxxxxxxxxx | $62802 | |
Nov 25, 2025 | xxxxxxxxxxxxx | $119796 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Dec 31, 2025 | xxxxxxxxxxxxx | $4397120 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $8807008 | |
Dec 31, 2025 | xxxxxxxxxxxxx | $11844742 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 863,613 | Institution | 3.09% | 62,361,495 | |
| 814,991 | Institution | 2.91% | 58,850,500 | |
| 791,000 | Institution | 2.83% | 57,118,110 | |
| 303,574 | Insider | 1.08% | 21,921,079 | |
| 290,569 | Institution | 1.04% | 20,981,987 | |
| 287,750 | Insider | 1.03% | 20,778,428 | |
| 280,150 | Institution | 1.00% | 20,229,632 | |
| 261,573 | Insider | 0.93% | 18,888,186 | |
| 255,934 | Institution | 0.91% | 18,480,994 | |
| 208,302 | Institution | 0.74% | 15,041,487 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 814,991 | Institution | 2.91% | 58,850,500 | |
| 290,569 | Institution | 1.04% | 20,981,987 | |
| 255,934 | Institution | 0.91% | 18,480,994 | |
| 189,447 | Institution | 0.68% | 13,679,968 | |
| 104,721 | Institution | 0.37% | 7,561,903 | |
| 90,000 | Institution | 0.32% | 6,498,900 | |
| 75,396 | Institution | 0.27% | 5,444,345 | |
| 48,934 | Institution | 0.17% | 3,533,524 | |
| 39,615 | Institution | 0.14% | 2,860,599 | |
| 32,895 | Institution | 0.12% | 2,375,348 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 594,509 | Institution | 2.12% | 22,193,021 | |
| 220,260 | Institution | 0.79% | 8,222,306 | |
| 130,755 | Institution | 0.47% | 9,577,804 | |
| 108,650 | Institution | 0.39% | 7,958,613 | |
| 71,766 | Institution | 0.26% | 5,182,223 | |
| 60,240 | Institution | 0.22% | 4,412,580 | |
| 51,066 | Institution | 0.18% | 3,740,585 | |
| 48,844 | Institution | 0.17% | 1,823,347 | |
| 28,129 | Institution | 0.10% | 2,060,449 | |
| 15,648 | Institution | 0.06% | 1,146,216 |
FAQ
Who Owns Nektar Therapeutics (NKTR)?
According to the latest TipRanks data, approximately 30.50% of the company's stock is held by institutional investors, 3.71% is held by insiders, and 53.35% is held by retail investors.
What percentage of Nektar Therapeutics (NKTR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 30.50% of Nektar Therapeutics (NKTR) stock is held by institutional investors.
What percentage of Nektar Therapeutics (NKTR) stock is held by retail investors?
According to the latest TipRanks data, approximately 53.35% of Nektar Therapeutics (NKTR) stock is held by retail investors.
Who owns the most shares of Nektar Therapeutics (NKTR)?
Vanguard owns the most shares of Nektar Therapeutics (NKTR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.